Gear Up for Corteva, Inc. (CTVA) Q4 Earnings: Wall Street Estimates for Key Metrics

03.02.25 15:16 Uhr

Werte in diesem Artikel
Aktien

59,78 EUR 0,48 EUR 0,81%

Indizes

6.066,4 PKT 40,5 PKT 0,67%

In its upcoming report, Corteva, Inc. (CTVA) is predicted by Wall Street analysts to post quarterly earnings of $0.34 per share, reflecting an increase of 126.7% compared to the same period last year. Revenues are forecasted to be $3.95 billion, representing a year-over-year increase of 6.5%.Over the last 30 days, there has been an upward revision of 2.5% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.With that in mind, let's delve into the average projections of some Corteva, Inc. metrics that are commonly tracked and projected by analysts on Wall Street.The collective assessment of analysts points to an estimated 'Revenue- Seed' of $1.70 billion. The estimate indicates a year-over-year change of +4.2%.Analysts expect 'Revenue- Crop Protection' to come in at $2.23 billion. The estimate suggests a change of +7.8% year over year.Analysts forecast 'Revenue- Crop Protection- Other' to reach $355.65 million. The estimate suggests a change of -2.3% year over year.The consensus estimate for 'Revenue- Seed- Other' stands at $127.79 million. The estimate points to a change of +15.1% from the year-ago quarter.It is projected by analysts that the 'Revenue- Crop Protection- Herbicides' will reach $1.04 billion. The estimate indicates a change of +5.4% from the prior-year quarter.Analysts predict that the 'Revenue- Crop Protection- Insecticides' will reach $505.04 million. The estimate indicates a year-over-year change of +14.3%.Based on the collective assessment of analysts, 'Revenue- Crop Protection- Fungicides' should arrive at $303.56 million. The estimate points to a change of +10.4% from the year-ago quarter.The consensus among analysts is that 'Revenue- Seed- Soybean' will reach $146.91 million. The estimate indicates a year-over-year change of +1.3%.The average prediction of analysts places 'Revenue- Seed- Corn' at $1.50 billion. The estimate indicates a year-over-year change of +14.8%.Analysts' assessment points toward 'Revenue- Seed- Other oilseeds' reaching $74.40 million. The estimate indicates a change of +4.8% from the prior-year quarter.The combined assessment of analysts suggests that 'Operating EBITDA- Seed' will likely reach $171.84 million. Compared to the current estimate, the company reported $145 million in the same quarter of the previous year.According to the collective judgment of analysts, 'Operating EBITDA- Crop Protection' should come in at $398.15 million. Compared to the present estimate, the company reported $267 million in the same quarter last year.View all Key Company Metrics for Corteva, Inc. here>>>Corteva, Inc. shares have witnessed a change of +16.7% in the past month, in contrast to the Zacks S&P 500 composite's +2.7% move. With a Zacks Rank #4 (Sell), CTVA is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Corteva, Inc. (CTVA): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Corteva

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Corteva

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Corteva Inc Registered Shs When Issued

Wer­bung

Analysen zu Corteva Inc Registered Shs When Issued

DatumRatingAnalyst
17.07.2019Corteva SellMonness, Crespi, Hardt & Co.
01.07.2019Corteva Equal WeightBarclays Capital
17.06.2019Corteva BuyDeutsche Bank AG
DatumRatingAnalyst
17.06.2019Corteva BuyDeutsche Bank AG
DatumRatingAnalyst
01.07.2019Corteva Equal WeightBarclays Capital
DatumRatingAnalyst
17.07.2019Corteva SellMonness, Crespi, Hardt & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Corteva Inc Registered Shs When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"